Bill Lundberg, M.D., has stepped down as CSO of CRISPR Therapeutics. News of Lundberg’s departure emerged on the same day Celgene revealed it has sold another chunk of its once-double-digit stake in the CRISPR/Cas9 gene editing startup.
A vast majority of accountable-care organizations in zero-risk contracts would reap additional savings if they took on downside risk because of the bonuses incurred as an advanced alternative payment model under MACRA, a new analysis finds.
Materials are one of the most common causes of failure in medical devices, especially for plastic. Records show that material failure is responsible for 30 to 40 percent of all FDA recalls on medical devices.
Cultivating a strong relationship with patients can translate into higher satisfaction scores but there is a widespread failure to communicate about the most appropriate way to reach consumers.
A San Francisco, California-based medical device startup, Zenflow, has announced a $31.4 million Series A financing round to further its minimally-invasive approach to treating benign prostatic hyperplasia (BPH) or enlarged prostate.
Paige.AI, a new company focused on revolutionizing clinical diagnosis and treatment in oncology through use of artificial intelligence (AI), launches today as it announces two major milestones
The Indian healthcare sector is growing at a fast pace because of increasing investments from government and private players. With nearly 70 percent of country's population living in rural areas, lack of critical medical facilities such as hospitals and clinics are in total disarray. With the rise of mobile technologies, the health apps are growing rapidly in the Indian market. As a result, mHealth (mobile delivery of healthcare) is gaining ground in India.
It had been a few years since the last systematic literature review of the effect health information technology (HIT) has on patient outcomes, and much has changed since. The Health Information Technology for Economic and Clinical Health (HITECH) Act of 2009 encouraged widespread electronic health record (EHR) adoption, vaulting them to near-ubiquity.
Amazon and two other American titans are trying to shake up health care by experimenting with their own employees’ coverage. By Chinese standards, they’re behind the curve.
Pfizer $PFE and J&J $JNJ have come down to the wire with pivotal data on nonmetastatic prostate cancer. And there are billions of dollars in revenue on the line here.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.